Association between ambient air pollution and hospitalization caused by atrial fibrillation.
Air Pollution
Atrial Fibrillation
Nitrogen Dioxide
Journal
ARYA atherosclerosis
ISSN: 1735-3955
Titre abrégé: ARYA Atheroscler
Pays: Iran
ID NLM: 101487337
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
entrez:
28
8
2019
pubmed:
28
8
2019
medline:
28
8
2019
Statut:
ppublish
Résumé
Many studies have shown the worst effects of air pollution on cardiovascular diseases (CVDs). Present study focused on the relationship between atrial fibrillation (AF), as one of the common arrhythmias, and air pollutants in Isfahan, Iran, an industrial city in the Middle East. A case-crossover design was used to explore the associations between air pollution and AF hospitalized patients with ventricular response (VR) > 90 beats per minute (bpm) (fast response) and those with VR ≤ 90 bpm. All patients' records were extracted from their hospital files. Air pollutants data including particulate matter less than 10 µ (PM10), PM2.5, carbon monoxide (CO), nitrogen dioxide (NO2), sulfur dioxide (SO2), and ozone (O3) were obtained from the Correlation of Air Pollution with Hospitalization and Mortality of Cardiovascular and Respiratory Diseases (CAPACITY) study. Conditional logistic regression test was used to measure the relationship between pollutants and hospitalization due to AF. Records of 369 patients, including 173 men (46.9%) who were hospitalized for AF during the study period and had complete data were extracted. Although a positive but not statistically significant relationship was shown between 10-unit increases in all pollutants (except PM10) and the hospitalization due to AF in patients with rapid VR (RVR), the only significant relationship was observed in case of NO2 [odds ratio (OR) = 1.26, 95% confidence interval (CI) = 1.0-2.1, P = 0.031]. This study showed positive significant relationships between NO2 and the hospitalization due to AF in patients with RVR. NO2 is a greenhouse gas whose levels are expected to increase due to global environmental changes. Therefore, relevant strategies should be adopted to decrease its levels, especially in industrial cities like Isfahan.
Sections du résumé
BACKGROUND
BACKGROUND
Many studies have shown the worst effects of air pollution on cardiovascular diseases (CVDs). Present study focused on the relationship between atrial fibrillation (AF), as one of the common arrhythmias, and air pollutants in Isfahan, Iran, an industrial city in the Middle East.
METHODS
METHODS
A case-crossover design was used to explore the associations between air pollution and AF hospitalized patients with ventricular response (VR) > 90 beats per minute (bpm) (fast response) and those with VR ≤ 90 bpm. All patients' records were extracted from their hospital files. Air pollutants data including particulate matter less than 10 µ (PM10), PM2.5, carbon monoxide (CO), nitrogen dioxide (NO2), sulfur dioxide (SO2), and ozone (O3) were obtained from the Correlation of Air Pollution with Hospitalization and Mortality of Cardiovascular and Respiratory Diseases (CAPACITY) study. Conditional logistic regression test was used to measure the relationship between pollutants and hospitalization due to AF.
RESULTS
RESULTS
Records of 369 patients, including 173 men (46.9%) who were hospitalized for AF during the study period and had complete data were extracted. Although a positive but not statistically significant relationship was shown between 10-unit increases in all pollutants (except PM10) and the hospitalization due to AF in patients with rapid VR (RVR), the only significant relationship was observed in case of NO2 [odds ratio (OR) = 1.26, 95% confidence interval (CI) = 1.0-2.1, P = 0.031].
CONCLUSION
CONCLUSIONS
This study showed positive significant relationships between NO2 and the hospitalization due to AF in patients with RVR. NO2 is a greenhouse gas whose levels are expected to increase due to global environmental changes. Therefore, relevant strategies should be adopted to decrease its levels, especially in industrial cities like Isfahan.
Identifiants
pubmed: 31452658
doi: 10.22122/arya.v15i3.1843
pii: ARYA-15-106
pmc: PMC6698081
doi:
Types de publication
Journal Article
Langues
eng
Pagination
106-112Références
Epidemiology. 2000 Jan;11(1):11-7
pubmed: 10615837
Epidemiology. 2001 May;12(3):355-7
pubmed: 11337606
Am J Med. 2002 Oct 1;113(5):359-64
pubmed: 12401529
Circulation. 2003 Dec 16;108(24):3006-10
pubmed: 14623805
Circulation. 2004 Oct 12;110(15):2184-9
pubmed: 15466639
Am J Epidemiol. 2005 Jun 15;161(12):1123-32
pubmed: 15937021
Environ Health Perspect. 2005 Aug;113(8):1052-5
pubmed: 16079078
East Mediterr Health J. 2004 Jan-Mar;10(1-2):147-51
pubmed: 16201720
Eur Heart J. 2006 Apr;27(8):936-41
pubmed: 16399778
Occup Environ Med. 2006 Sep;63(9):591-6
pubmed: 16698809
J Am Coll Cardiol. 2007 Mar 6;49(9):986-92
pubmed: 17336723
J Epidemiol Community Health. 2008 Mar;62(3):267-72
pubmed: 18272743
Hypertension. 2009 May;53(5):853-9
pubmed: 19273743
Chest. 2010 Feb;137(2):263-72
pubmed: 19762550
Curr Opin Cardiol. 2010 Jan;25(1):16-22
pubmed: 19881339
Circulation. 2010 Jun 1;121(21):2331-78
pubmed: 20458016
Neurology. 2011 Mar 8;76(10):914-22
pubmed: 21383328
Thromb Res. 2012 Mar;129(3):230-4
pubmed: 22113148
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):85-93
pubmed: 22235070
J Am Coll Cardiol. 2013 Aug 27;62(9):816-25
pubmed: 23770178
Eur Heart J. 2013 Sep;34(35):2746-51
pubmed: 23900699
JAMA Intern Med. 2014 Jan;174(1):107-14
pubmed: 24190540
Heart. 2014 Jul;100(14):1093-8
pubmed: 24952943
Lancet. 2015 Jul 11;386(9989):154-62
pubmed: 25960110
Eur J Neurol. 2016 Feb;23(2):262-9
pubmed: 26041584
Epidemiol Health. 2016 May 17;38:e2016019
pubmed: 27188309
PLoS One. 2017 May 17;12(5):e0175405
pubmed: 28520719
Int J Environ Res Public Health. 2017 Jun 20;14(6):
pubmed: 28632149
ARYA Atheroscler. 2017 Nov;13(6):264-273
pubmed: 29643921